| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5693943 | European Urology | 2017 | 8 Pages |
Abstract
The aim of precision cancer prevention is to tailor interventions on the basis of individualized patient characteristics. We propose that patients with low NKX3.1 expression are optimal candidates for intervention with 5α-reductase inhibitors as an adjunct to active surveillance.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Aditya Dutta, Sukanya Panja, Renu K. Virk, Jaime Yeji Kim, Roseann Zott, Serge Cremers, David M. Golombos, Deli Liu, Juan Miguel Mosquera, Elahe A. Mostaghel, Christopher E. Barbieri, Antonina Mitrofanova, Cory Abate-Shen,